Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-15-177730
Filing Date
2015-05-08
Accepted
2015-05-07 20:14:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D d923086dsc13d.htm SC 13D 55798
2 EX-99.1 d923086dex991.htm EX-99.1 11785
  Complete submission text file 0001193125-15-177730.txt   69189
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filed by) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11119 NORTH TORREY PINES ROAD, SUITE 50 SAN DIEGO CA 92037
Business Address 11119 NORTH TORREY PINES ROAD, SUITE 50 SAN DIEGO CA 92037 858-550-7810
Viking Therapeutics, Inc. (Subject) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88828 | Film No.: 15843698
SIC: 2834 Pharmaceutical Preparations